BioSpace News Archive

Talis Biomedical Corporation announced it has initiated a process to explore strategic alternatives with the goal of maximizing shareholder value.

Vittoria Biotherapeutics announced it has secured over $15 million in a private financing round.

RedHill Biopharma Ltd., a specialty biopharmaceutical company, announced that it has received approval from the Listing Qualifications Department of The Nasdaq Stock Market LLC to transfer the listing of the American Depositary Shares to the Nasdaq Capital Market.

EMulate Therapeutics, Inc. (EMTx) proudly announced today the acceptance of their abstract for presentation and publication in the 28th Annual Meeting and Education Day of the Society for Neuro-Oncology (SNO), November 2023, in Vancouver, British Columbia.

Revvity, Inc. (NYSE: RVTY) will present at the 6th Annual Evercore ISI HealthCONx Conference on Tuesday, November 28, 2023 at 9:10 a.m. ET in Miami, FL.

GeneCentric Therapeutics today announced the appointment of Prasanth Reddy, MD, MPH, FACP, and Don Hardison as independent directors of its Board of Directors.

Aptevo Therapeutics Inc. today reported financial results for the quarter ended September 30, 2023 and provided a business update.

Jaguar Health, Inc. today reported consolidated third-quarter 2023 financial results and provided Company updates.

ReWalk Robotics Ltd. today announced its financial results for the three and nine months ended September 30, 2023.

NImmune Biopharma will be presented at the American College of Rheumatology’s (ACR) annual meeting. ACR Convergence 2023 will take place from November 10-15, 2023, at the San Diego Convention Center in San Diego, California, with NImmune’s poster presentation to take place on Tuesday, November 14 from 9:00 am – 11:00 am.